CNTXVSPCSA• 6 Months (Normalized)
CNTX vs PCSA (Context Therapeutics Inc. vs Processa Pharmaceuticals Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CNTX Performance $0.35
-88.56%
Context Therapeutics Inc.
Normalized Baseline0.00%
PCSA Performance $2.08
-33.33%
Processa Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin PCSA LEADS
-55.23%
PCSA outperforming by 55.23%
CNTXPCSA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CNTX PCSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | CNTX Price | CNTX Gain (%) | PCSA Price | PCSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.35 | -88.56% | $2.08 | -33.33% | -55.23% |
| Sep 10, 2026 | $0.37 | -88.04% | $1.85 | -40.71% | -47.33% |
| Sep 09, 2026 | $0.37 | -87.91% | $1.99 | -36.22% | -51.69% |
| Sep 08, 2026 | $0.38 | -87.71% | $2.16 | -30.77% | -56.94% |
| Sep 04, 2026 | $0.36 | -88.17% | $2.06 | -33.97% | -54.20% |
| Sep 03, 2026 | $0.36 | -88.14% | $2.05 | -34.29% | -53.85% |
| Sep 02, 2026 | $0.36 | -88.14% | $2.10 | -32.69% | -55.45% |
| Sep 01, 2026 | $0.36 | -88.10% | $2.05 | -34.29% | -53.81% |
| Aug 31, 2026 | $0.39 | -87.25% | $2.05 | -34.29% | -52.96% |
| Aug 28, 2026 | $0.38 | -87.45% | $2.06 | -33.97% | -53.48% |
| Aug 27, 2026 | $0.42 | -86.41% | $2.11 | -32.37% | -54.04% |
| Aug 26, 2026 | $0.42 | -86.14% | $2.13 | -31.73% | -54.41% |
| Aug 25, 2026 | $0.44 | -85.78% | $2.18 | -30.13% | -55.65% |
| Aug 24, 2026 | $0.47 | -84.80% | $2.17 | -30.45% | -54.35% |
| Aug 21, 2026 | $0.50 | -83.66% | $2.08 | -33.33% | -50.33% |
Page 1 of 9